Emergent Biosolutions Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.80

-0.22 (-3.13%)

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 5 71%

Hold 1 14%

Sell 1 14%

Price Target

Analyst Price Target +298.2% upside

Low Target $18.81

Average Target $27.08

High Target $37.55

Current Price $6.80

Current
$6.80

Target
$27.08

$18.81 $27.08 avg $37.55

Scenario Analysis

Bear Case

$18.81

176.6%

Low target

Base Case

$27.08

+298.2%

Avg target

Bull Case

$37.55

+452.2%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$14.06

-51.6% from high

52-Week Low

$4.36

+56.0% from low

Target vs 52W High

$27.08

+92.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.2%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%